EE200300566A - AMPA retseptori allosteerilised positiivsed naftotiasiin-modulaatorid - Google Patents

AMPA retseptori allosteerilised positiivsed naftotiasiin-modulaatorid

Info

Publication number
EE200300566A
EE200300566A EEP200300566A EEP200300566A EE200300566A EE 200300566 A EE200300566 A EE 200300566A EE P200300566 A EEP200300566 A EE P200300566A EE P200300566 A EEP200300566 A EE P200300566A EE 200300566 A EE200300566 A EE 200300566A
Authority
EE
Estonia
Prior art keywords
naphthothiazine
modulators
ampa receptor
receptor allosteric
allosteric positive
Prior art date
Application number
EEP200300566A
Other languages
English (en)
Estonian (et)
Inventor
Ceci Angelo
Klinder Klaus
Weiser Thomas
Winter Karin
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300566A publication Critical patent/EE200300566A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EEP200300566A 2001-05-17 2002-05-15 AMPA retseptori allosteerilised positiivsed naftotiasiin-modulaatorid EE200300566A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
EE200300566A true EE200300566A (et) 2004-02-16

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300566A EE200300566A (et) 2001-05-17 2002-05-15 AMPA retseptori allosteerilised positiivsed naftotiasiin-modulaatorid

Country Status (26)

Country Link
EP (1) EP1404340A1 (zh)
JP (1) JP2004529980A (zh)
KR (1) KR20040007572A (zh)
CN (1) CN1533278A (zh)
AR (1) AR036332A1 (zh)
BG (1) BG108324A (zh)
BR (1) BR0209796A (zh)
CA (1) CA2449189A1 (zh)
CO (1) CO5550460A2 (zh)
CZ (1) CZ20033112A3 (zh)
DE (1) DE10123952A1 (zh)
EA (1) EA006608B1 (zh)
EC (1) ECSP034852A (zh)
EE (1) EE200300566A (zh)
HR (1) HRP20030933A2 (zh)
HU (1) HUP0401273A3 (zh)
IL (1) IL158642A0 (zh)
MX (1) MXPA03010373A (zh)
NO (1) NO20035088L (zh)
NZ (1) NZ530154A (zh)
PL (1) PL364053A1 (zh)
SK (1) SK14222003A3 (zh)
UY (1) UY27290A1 (zh)
WO (1) WO2002100411A1 (zh)
YU (1) YU90403A (zh)
ZA (1) ZA200308466B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047534A (ko) * 2006-08-31 2009-05-12 더 거버너스 오브 더 유니버시티 오브 앨버타 양성 알로스테릭 ampa 수용체 조절인자를 사용하여 호흡 저하를 억제하는 방법
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
JP2002518498A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド ナフト[1,8−de]チアジン−2−イルメチルカルバペネム抗菌物質
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
AR036332A1 (es) 2004-09-01
NZ530154A (en) 2005-09-30
ZA200308466B (en) 2004-05-24
MXPA03010373A (es) 2004-03-16
CZ20033112A3 (en) 2004-03-17
CO5550460A2 (es) 2005-08-31
BG108324A (bg) 2004-12-30
HUP0401273A2 (hu) 2004-10-28
IL158642A0 (en) 2004-05-12
CA2449189A1 (en) 2002-12-19
KR20040007572A (ko) 2004-01-24
HRP20030933A2 (en) 2004-04-30
ECSP034852A (es) 2003-12-24
PL364053A1 (en) 2004-12-13
JP2004529980A (ja) 2004-09-30
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
UY27290A1 (es) 2002-12-31
EA200301167A1 (ru) 2004-06-24
BR0209796A (pt) 2004-06-01
EP1404340A1 (en) 2004-04-07
DE10123952A1 (de) 2002-11-21
WO2002100411A1 (en) 2002-12-19
HUP0401273A3 (en) 2006-11-28
EA006608B1 (ru) 2006-02-24
YU90403A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
ATE293962T1 (de) Adenosin-rezeptor modulatoren
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
ATE544762T1 (de) Calcium rezeptor modulatoren
NO20023663L (no) Broplugg
DE60233024D1 (de) Trockentoner
AU2003290778A8 (en) Non-steroidal farnesoid x receptor modulators
IL158038A0 (en) Allosteric adenosine receptor modulators
DE60204770D1 (de) Scharnier
ATE459598T1 (de) Sulfonamidderivate
NO20035183D0 (no) 5-substituerte-2-arylpyridiner som CRF1 modulatorer
DE60216980D1 (de) Client-server kommunikationssystem
DE60222693D1 (de) Nk1-antagonisten
DE50200230D1 (de) Tripodegelenk
DE60324919D1 (de) Viskosedämpfer
DE50214751D1 (de) Dosiervorrichtung
DE60201256D1 (de) Elektrooptischer wanderwellenmodulator
DE50200210D1 (de) Tripodegelenk
EE200300566A (et) AMPA retseptori allosteerilised positiivsed naftotiasiin-modulaatorid
FR2831625B1 (fr) Joint homocinetique de type tripode
ATA5002002A (de) Vibrator
DE50213194D1 (de) Abstreifer
DE60232564D1 (de) Fixiergerät
ATA8202001A (de) Medikamentenapplikator
DE60223671D1 (de) Dosierpumpe
DE50213685D1 (de) Dosiervorrichtung